A carregar...
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
OBJECTIVE: HER2 overexpression is associated with aggressive phenotypes in breast cancer, including increased tumor proliferation, greater invasiveness, and reduced overall survival. The overall response rate to HER2-targeted therapies remains <30%. There is an urgent need for the identification...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367898/ https://ncbi.nlm.nih.gov/pubmed/28356761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S132806 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...